The HOST-BR trial found that a 3-month dual antiplatelet therapy regimen after percutaneous coronary intervention balances ischemic and bleeding risks. The post HOST-BR: Searching for the Optimal Duration of DAPT […]
The post HOST-BR: Searching for the Optimal Duration of DAPT After PCI first appeared on Blackandmed .
